治疗性血浆置换在严重甲状腺毒症中的应用:病例系列临床观察
该病例系列描述了6例严重甲状腺毒症或甲状腺风暴患者接受治疗性血浆置换(TPE)作为甲状腺切除术桥接治疗的临床特征与结局,旨在提出术前甲状腺激素目标。结果显示TPE可有效降低fT4水平,术前fT4目标可考虑2.5-3.3 ng/dL。
要点
- TPE可作为严重甲状腺毒症患者术前桥接治疗以降低甲状腺激素水平
- 术前fT4目标可考虑2.5-3.3 ng/dL
- 达到术前fT4 2.5 ng/dL平均需5.5次TPE治疗
核心结论
- TPE作为甲状腺切除术桥接治疗有效,术前fT4目标可考虑2.5-3.3 ng/dL。
研究设计与样本
- 病例系列研究,收集2023年4月至2024年4月间6例因高死亡风险或药物治疗无效而接受TPE的严重甲状腺毒症或甲状腺风暴患者数据。
主要发现
- 6例中4例接受甲状腺切除术,2例死于多器官功能衰竭。
- 诊断时平均fT4为4.8 ng/dL(参考范围0.8-1.8 ng/dL),TPE前为5.4 ng/dL,甲状腺切除术前为2.6 ng/dL。
关键数值与推荐
- 术前fT4目标可考虑2.5-3.3 ng/dL。
临床怎么用
- 对药物治疗无效的严重甲状腺毒症或甲状腺风暴患者,可考虑TPE作为甲状腺切除术前的桥接治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Severe thyrotoxicosis and thyroid storm have a high morbidity and mortality risk and are commonly managed with antithyroid drugs. In some patients, a combination therapy with medications and thyroidectomy as definite treatment are required. Therapeutic Plasma Exchange (TPE) can be used as a temporizing measure to achieve thyroid hormone normalization and to prevent perioperative complications before surgery. OBJECTIVE: We describe 6 cases of severe thyrotoxicosis and/or thyroid storm who underwent TPE as a bridge to thyroidectomy and present the clinical characteristics and outcomes. We aim to propose a preoperative thyroid hormone target. METHODS: We collected data of 6 patients who were diagnosed with severe thyrotoxicosis or thyroid storm between April 2023 and April 2024 and that were treated with TPE due to high mortality risk or refractoriness to medical treatment. Data collected included the baseline clinical characteristics, laboratory data, clinical progress, and outcomes. Thyroid hormone levels at diagnosis, before initiation of TPE, and before thyroidectomy were compared using statistical analysis. RESULTS: Four of 6 patients underwent thyroidectomy, and 2 patients died due to multiorgan dysfunction. The mean free T4 (fT4) level at diagnosis was 4.8 ng/dL (reference range, 0.8-1.8 ng/dL), 5.4 ng/dL pre-TPE, and 2.6 ng/dL prethyroidectomy, resulting in a mean difference of 2.8 ng/dL (51.7%) reduction (95% CI, 1.1-4.5; P = .01). The number of TPE treatments to reach a preoperative fT4 level of 2.5 ng/dL was 5.5 treatments (P = .03). CONCLUSION: These results reflect efficacy of TPE as a bridge to thyroidectomy and suggest that a preoperative fT4 goal of 2.5 to 3.3 can be considered in patients with severe thyrotoxicosis and thyroid storm that are refractory to medical treatment.
引用
- Calderon A, Aguilera M, Drinnon AR, et al. Therapeutic Plasma Exchange in Severe Thyrotoxicosis: Clinical Observations From a Case Series. J Clin Endocrinol Metab. 2026. PMID: 41557149. doi:10.1210/clinem/dgaf649
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。